Healthcare Roundup – Lilly bamlanivimab combo therapy lowers COVID-19 hospitalizations, JNJ earnings release brightens U.S. biopharma outlook Jan 26, 2021 Life Science
Healthcare Roundup- Merck discontinues development of V590 and V591 COVID-19 vaccine candidates, Moderna’s COVID-19 jab retains neutralizing activity against emerging virus variants Jan 25, 2021 Life Science
Healthcare Roundup – Intuitive Surgical earns mixed reviews from analysts despite earnings beat; Amyris acquires Terasana Brand for offering clean cannabinoid consumer products Jan 22, 2021 Life Science
Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest Jan 21, 2021 Life Science
HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel Jan 21, 2021 Life Science
Healthcare Roundup – Adamis Pharma soars on Tempol IND submission for COVID-19 treatment; MindMed kicks off early stage trial for LSD-MDMA cocktail Jan 20, 2021 Life Science
Healthcare Roundup – Moderna drops as company acknowledges allergic reactions to COVID-19 shot, Eli Lilly upgraded to buy at Mizuho on positive donanemab data Jan 19, 2021 Life Science
HempFusion’s Wholly Owned Subsidiary Probulin Probiotics Launches Amazon Store and Expands Brick and Mortar Product Selection Jan 19, 2021 Life Science
Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September；Grifols to trial new immunoglobulin therapy against COVID-19 Jan 18, 2021 Life Science
Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analyst Jan 15, 2021 Life Science
Healthcare Roundup – The world will have to live with COVID forever; Gilead attributes long term growth to oncology franchise, excludes remdesivir Jan 14, 2021 Life Science
Healthcare Roundup – JNJ’s COVID-19 vaccine data published in Medical Journal, Evolus is up 6% after AbbVie-Cypris Medical deal Jan 14, 2021 Life Science
Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study Jan 12, 2021 Life Science
Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences Jan 9, 2021 Life Science
